Pre-Operative Risk Factors of Bleeding and Stroke During Left Ventricular Assist Device Support
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVES This study sought to determine the pre-operative risk factors related to late bleeding, stroke, and pump thrombosis in patients with HeartMate II (HMII) left ventricular assist devices (LVADs) (Thoratec Corporation, Pleasanton, California) that might influence tailored improvements in patient management. BACKGROUND Adverse events in LVAD patients remain high. It is unclear whether pre-operative characteristics influence the likelihood of the development of post-operative hemorrhagic or thrombotic complications. Knowing which patients are at greater risk might assist in tailoring anticoagulation therapy for certain patients. METHODS Advanced heart failure patients (n = 956) discharged from the hospital after LVAD implantation in the HMII bridge to transplantation (n = 405) and destination therapy (n = 551) clinical trials were retrospectively evaluated. Bleeding requiring surgery or transfusion of >2 U of packed red blood cells, stroke (hemorrhagic and ischemic), and pump thrombosis were tracked from hospital discharge until patient outcome. RESULTS Adverse event rates for post-discharge bleeding (0.67 events/patient-year) were higher than those for hemorrhagic stroke (0.05), ischemic stroke (0.04), and pump thrombosis (0.03). The main sites of bleeding included gastrointestinal (45% of events), wound (12%), and epistaxis (4%). Older age (>65 years) (hazard ratio [HR]: 1.31), lower pre-operative hematocrit (≤31%) (HR: 1.31), ischemic etiology (HR: 1.35), and female (HR: 1.45) were statistically significant multivariable risk factors for bleeding. Female (HR: 1.92) and 65 years of age and younger (HR: 1.94) were multivariable risk factors for hemorrhagic stroke, whereas female (HR: 1.84) and history of diabetes (HR: 1.99) were risk factors for ischemic stroke. Female (HR: 1.90) and higher body mass index (HR: 1.71/10 kg/m(2) increase) were also multivariable risk factors for pump thrombosis. CONCLUSIONS The risk of bleeding and thrombotic events during LVAD support differs by patient demographics, including sex, age, body mass index, and etiology of heart failure. Further studies should focus on the potential of tailored anticoagulation strategies in these subgroups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced heart failure treated with continuous-flow left ventricular assist device
Slaughter, M. S., Rogers, J. G., Milano, C. A., Russell, S. D., Conte, J. V., Feldman, D., Sun, B., Tatooles, A. J., Delgado, R. M., Long, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0909938 · Cited by 3,063 · cited 14×
“The HeartMate II bridged by Thoratec Corporation.”
BackgroundMethodSelf-citationUse of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
Miller, L. W., Pagani, F. D., Russell, S. D., John, R., Boyle, A. J., Aaronson, K. D., Conte, J. V., Naka, Y., Mancini, D., Delgado, R. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067758 · Cited by 1,733 · cited 5×
“Pump thrombosis 38 (4) 7 (2) 31 (6) 43 (0.”
BackgroundMethodSelf-citationClinical management of continuous-flow left ventricular assist devices in advanced heart failure
Slaughter, M. S., Pagani, F. D., Rogers, J. G., Miller, L. W., Sun, B., Russell, S. D., Starling, R. C., Chen, L., Boyle, A. J., Chillcott, S., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.01.011 · Cited by 874 · cited 1×
“5 in the absence of an additional indication for warfarin (11,12).”
BackgroundSelf-citationExtended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist Device
Pagani, F. D., Miller, L. W., Russell, S. D., Aaronson, K. D., John, R., Boyle, A. J., Conte, J. V., Bogaev, R. C., MacGillivray, T. E., Naka, Y., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.055 · Cited by 869 · cited 2×
“67) Male (n 1⁄4 736) 712 (97) 24 (3) Ischemic cardiomyopathy (n 1⁄4 506) 491 (97) 15 (3) 0.”
Self-citationRisk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819 · cited 1×
“The use of oral contraceptives or hormone replacement therapy has been associated with an increased risk of venous thromboembolism (21,22).”
BackgroundUriel, N. Y., Pak, S., Jorde, U. P., Jude, B., Susen, S., Vincentelli, A., Ennezat, P. V., Cappleman, S., Naka, Y., & MANCINI, D. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.016 · Cited by 607 · cited 2×
“Hemorrhagic stroke 76 (8) 25 (6) 51 (9) 80 (0.”
Self-citationOral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579 · cited 2×
“GI bleeding 213 (22) 52 (13) 161 (29) 518 (0.”
BackgroundCrow, S., John, R., Boyle, A., Shumway, S., Liao, K., Colvin-Adams, M., Toninato, C., Missov, E., Pritzker, M., Martin, C., et al. (2009) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.07.032 · Cited by 486 · cited 1×
“GI bleeding 213 (22) 52 (13) 161 (29) 518 (0.”
Self-citationAcquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients
Crow, S. S., Chen, D., Milano, C. A., Thomas, W., Joyce, L. D., Piacentino, V., Sharma, R., Wu, J. R., Arepally, G. M., Bowles, D. E., et al. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.04.099 · Cited by 388 · cited 6×
“Pump thrombosis 38 (4) 7 (2) 31 (6) 43 (0.”
Self-citationDemirozu, Z. T., Radovancevic, R., Hochman, L. F., Gregoric, I. D., Letsou, G. V., Kar, B., Bogaev, R. C., & Frazier, O. H. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.03.008 · Cited by 356 · cited 1×
“Sex Female (n 1⁄4 220) 189 (86) 31 (14) 0.”
Self-citationPark, S. J., Milano, C. A., Tatooles, A. J., Rogers, J. G., Adamson, R. M., Steidley, D. E., Ewald, G. A., Sundareswaran, K. S., Farrar, D. J., Slaughter, M. S., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963991 · Cited by 341
Self-citationGeisen, U., Heilmann, C., Beyersdorf, F., Benk, C., Berchtold-Herz, M., Schlensak, C., Budde, U., & Zieger, B. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.12.047 · Cited by 331 · cited 1×
“Sex Female (n 1⁄4 220) 199 (90) 21 (10) 0.”
Boyle, A. J., Russell, S. D., Teuteberg, J. J., Slaughter, M. S., Moazami, N., Pagani, F. D., Frazier, O. H., Heatley, G., Farrar, D. J., & John, R. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.05.018 · Cited by 300 · cited 2×
“5 in the absence of an additional indication for warfarin (11,12).”
BackgroundSelf-citationAge at Natural Menopause and Risk of Ischemic Stroke: The Framingham Heart Study
Lisabeth, L. D., Beiser, A. S., Brown, D. L., Murabito, J. M., Kelly-Hayes, M., & Wolf, P. A. (2009) · Stroke · doi:10.1161/strokeaha.108.542993 · Cited by 230 · cited 1×
“The Framingham Heart Study found that women with natural menopause before 42 years of age had twice the ischemic stroke risk than those with a natural menopause after the age of 42 years (23).”
BackgroundGastrointestinal bleeding with the HeartMate II left ventricular assist device
Morgan, J. A., Paone, G., Nemeh, H. W., Henry, S. E., Patel, R., Vavra, J., Williams, C. T., Lanfear, D. E., Tita, C., & Brewer, R. J. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.02.015 · Cited by 168
Kato, T. S., Schulze, P. C., Yang, J., Chan, E., Shahzad, K., Takayama, H., Uriel, N., Jorde, U., Farr, M., Naka, Y., et al. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.08.014 · Cited by 130 · cited 1×
“Previous single-center studies have identified history of cerebrovascular accident, serum sodium, and serum albumin (18) and right atrial pressure and right ventricular enddiastolic dimension (19) as pre-operative risk factors for post-LVAD ischemic and hemorrhagic stroke.”
BackgroundSelf-citationBogaev, R. C., Pamboukian, S. V., Moore, S. A., Chen, L., John, R., Boyle, A. J., Sundareswaran, K. S., Farrar, D. J., & Frazier, O. H. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.12.009 · Cited by 104 · cited 1×
“(20) in 104 women and 361 men found a higher hemorrhagic stroke rate (0.”
BackgroundSelf-citationJohn, R., Naka, Y., Smedira, N. G., Starling, R. C., Jorde, U. P., Eckman, P., Farrar, D. J., & Pagani, F. D. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.05.080 · Cited by 101 · cited 3×
“02 Male (n 1⁄4 736) 699 (95) 37 (5) BMI, kg/m(2) 27.”
ResultSelf-citationMenon, A. K., Götzenich, A., Saßmannshausen, H., Haushofer, M., Autschbach, R., & Spillner, J. W. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezr312 · Cited by 54 · cited 1×
“Compared with bleeding, the risks of stroke and pump thrombosis with the HMII have been shown to be low, both in single-center and multicenter experiences (11,16,17).”
Background
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000691 · Cited by 639
INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices
Acharya, D., Loyaga-Rendon, R., Morgan, C. J., Sands, K. A., Pamboukian, S. V., Rajapreyar, I., Holman, W. L., Kirklin, J. K., & Tallaj, J. A. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.06.014 · Cited by 170
“(12,18,19) In this report, female gender was an independent predictor of both ischemic and hemorrhagic strokes.”
BackgroundDunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145
Metadata
- Authors
- Boyle, A. J., Jorde, U. P., Sun, B., Park, S. J., Milano, C. A., Frazier, O. H., Sundareswaran, K. S., Farrar, D. J., & Russell, S. D.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 63
- Issue
- 9
- Pages
- 880-888
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W155942078
- Cited by
- 217
- References
- 19
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.